Skip to main content
. Author manuscript; available in PMC: 2010 Jul 6.
Published in final edited form as: Cancer. 2009 Apr 15;115(8):1765–1775. doi: 10.1002/cncr.24175

Table 2.

Summary of Dose-Limiting Toxicities

Dose Level
No.
Entered
No.
Evaluable
No.
DLTs
DLTs
(# patients)

Oxaliplatin
(mg/m2/dose)
Irinotecan
(mg/m2/dose)
Diarrhea (3)
Lipase (3)
60 20 3 3 3 Amylase (2)
Colitis (1)
Abdominal Pain (1)
Headache (1)

40 15 7* 6 1 Diarrhea (1)

60 15 3 3 2 Diarrhea (1)
Hypokalemia (1)
*

One patient received an incorrect irinotecan dose of 20 mg/m2/d